IsoPlexis Corporation Common Stock
ISO was delisted on the 20th of March, 2023.
30 hedge funds and large institutions have $28.3M invested in IsoPlexis Corporation Common Stock in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 2 closing their positions.
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
36% more funds holding
Funds holding: 22 → 30 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less capital invested
Capital invested by funds: $31.8M → $28.3M (-$3.57M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$2.96M |
| 2 |
Morgan Stanley
New York
|
+$755K |
| 3 |
E
Ergoteles
New York
|
+$323K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$236K |
| 5 |
JC
JBF Capital
Aspen,
Colorado
|
+$195K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.34M |
| 2 |
ABG
Ally Bridge Group
New York
|
-$2.62M |
| 3 |
Millennium Management
New York
|
-$105K |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$4.15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.33K |
ISO Hedge Fund Activity: Q4 2022 in Review
30 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in IsoPlexis Corporation Common Stock (ISO) for Q4 2022, worth a combined $28.3M — down 11% from $31.8M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ISO positions and 2 closed out — a net gain of 9 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Glenview Capital Management, opening a new position worth an estimated $2.96M. The largest seller was BlackRock, cutting an estimated $3.34M.
- 30 institutional investors held IsoPlexis Corporation Common Stock (ISO) as of Q4 2022, up from 22 in Q3 2022.
- Funds reported $28.3M of IsoPlexis Corporation Common Stock stock for Q4 2022, down 11% quarter-over-quarter.
- 11 funds opened new IsoPlexis Corporation Common Stock positions in Q4 2022 and 2 closed out, a net change of +9 holders.
- The largest IsoPlexis Corporation Common Stock buyer in Q4 2022 was Glenview Capital Management, an estimated $2.96M added.
- The largest IsoPlexis Corporation Common Stock seller in Q4 2022 was BlackRock, an estimated $3.34M sold.
Based on aggregated 13F filings for Q4 2022.